Shri Dharmasthala Manjunatheshwara University

Research and Development Cell

The Directorate of Research coordinates SDM University’s Research & Development Cell. Between 2019 and 2025 the Cell mobilised ₹ 749.34 lakh through twenty-nine competitive grants: Medical Sciences ₹ 404.24 lakh, Dental ₹ 114.49 lakh, CCMS ₹ 125.11 lakh, RIBS ₹ 105.54 lakh and Physiotherapy ₹ 2.96 lakh, supported by agencies such as ICMR, DST-SERB, NIH (USA) and the Ministry of AYUSH.

Flagship projects illustrate the Cell’s reach: the TOPSPIN blood-pressure optimisation trial with Imperial College London, the ₹ 158.6-lakh hiPSC-derived granulocyte programme for drug-resistant sepsis, an indigenous zirconium-oxide biomaterials study with India’s DBT, and the DST-funded Cervical Microbiome Diversity project. More than thirty active MoUs underpin foreign and industry collaborations, ranging from the University of Manitoba to IIT-Dharwad, Cambrian Bioworks, Bosch India and Cellagility Biomed.

Research output has doubled in five years: 1,111 peer-reviewed publications indexed in Scopus/Web of Science, four patents granted and five filed, alongside a four-fold rise in new grant applications last year. Consultancy assignments, proposal-to-patent clinics and IPR mentoring (via Dhara Consultancy and CCAMP-Bengaluru) are channelled through the Cell to ensure seamless translation from bench to community.

CRL
RIBS
CCMS

Central Research Laboratory (CRL) provides institution-wide access to advanced molecular and analytical platforms—twenty-one centrifuges, multiple PCR systems, HPLC, Lyophilizer and more—supporting routine testing, consultancy work and student training.

SDM Research Institute for Biomedical Sciences (RIBS) drives projects on the microbiome–immune–cancer axis, translational glycobiology and computational biology, contributing over fifty original publications. Its core houses six biosafety cabinets, five CO₂ incubators, automated cell counters, real-time PCR, molecular imagers, −80 °C biorepository freezers and a full suite of GLP-grade instrumentation. RIBS also supports research on stem-cell, immunogenetics, with an advanced pharmaceutical-grade clean room.

Centre for Cellular & Molecular Sciences (CCMS) and currently leads externally funded studies on epigenetics, cancer, host-pathogen interactions and traditional medicine. With the state of the art facilities, researchers are also striving to implement various advanced diagnostic tests for human diseases.